Beta Cell Transplant
Beta Cell Transplant - Related Videos
02:25
An Assay for Analyzing Test β-Glucan as an Immunotherapy Strategy against Brain Cancer Cells
0 Views •
2025
This video demonstrates an in vitro assay utilizing β-glucans to activate microglial cells for the production of superoxide radicals, a reactive oxygen species. In brain cancer cells, the generated reactive oxidants actively suppress tumor cell proliferation and induce cell death.
09:50
In situ Quantification of Pancreatic Beta-cell Mass in Mice
0 Views •
Cited by 6 •
2010
The following protocol outlines the process of pancreatic dissection for virtual slice imaging, and the subsequent quantification of all GFP-tagged beta-cells in the entire pancreas.
18:48
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
0 Views •
Cited by 1 •
2017
Here, we present a protocol to induce tolerance in transplantation, and assess in vitro and in vivo the suppressive capacity of distinct cell subsets from the recipient and the immune status of the recipient toward donor or exogenous antigens.
12:12
Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
0 Views •
Cited by 14 •
2011
Cell-mediated lymphocytotoxicity (CML) assays can be used to test autoreactive responses and study mechanisms of cell death in vitro. However, using live-cell confocal microscopic imaging techniques with fluorescent dyes, the type and kinetics of cell death as well as the pathways utilized can be studied in greater detail.
01:25
Beta
0 Views •
2024
Beta is a crucial metric in finance used to assess an investment's risk and expected return relative to the overall market. It is calculated as the slope of the line in a scatterplot that compares the returns of an individual stock to the returns of the market benchmark, typically represented by a broad market index. Beta quantifies how much a stock's price moves in response to market movements, providing insight into its volatility and systematic risk. A beta of one indicates that the stock's...
FAQs
The transplanted cells retain the central biological role of pancreatic beta cells: they sense blood glucose and release insulin accordingly. This regulated response is important because it links the graft’s activity to the recipient’s immediate glucose state rather than providing insulin independently of metabolic conditions. Effective glucose sensing and insulin release therefore contribute directly to improved glycemic control.
Newly transplanted cells require access to blood for survival and function. An adequate blood supply supports their ability to detect circulating glucose and release insulin into the recipient’s circulation. Without successful engraftment, the cells may not remain functional enough to regulate glucose effectively. Blood supply is therefore a key biological condition determining whether the graft can provide sustained benefit.
The recipient’s immune system can recognize transplanted beta cells as foreign and damage or eliminate them, a process known as immune-mediated rejection. Preserving graft function therefore requires protection from this response. Clinical approaches may include immunosuppressive treatment, while research also examines immune protection strategies that could help maintain functioning cells over a longer period.
Durable insulin independence depends on the continued function of the transplanted cells, successful engraftment, adequate blood supply, and protection from immune-mediated rejection. If these conditions are maintained, the graft may continue sensing glucose and releasing insulin. Ongoing research into stem cell-derived beta cells and immune protection reflects the challenge of making this benefit reliable and long-lasting.
A common clinical approach places donor islets in the liver through the portal vein, the vessel route used to access the liver. This procedure introduces the insulin-producing cell clusters into the recipient so they can engraft and interact with the circulation. The success of this approach still depends on adequate blood supply and preservation of graft function.
This therapy is particularly relevant to people with type 1 diabetes because restoring insulin-producing cells can address the loss of beta cell function underlying impaired glucose regulation. Its potential clinical value includes reducing severe hypoglycemia and improving glycemic control. The approach is therefore studied as a cell replacement strategy rather than simply as a way to deliver insulin externally.
Beta cell transplantation can reduce severe hypoglycemia and improve glycemic control when the graft remains functional. However, maintaining benefit requires durable engraftment and protection from immune-mediated rejection, and recipients may need immunosuppressive treatment. Current research focuses on stem cell-derived beta cells, immune protection, and achieving insulin independence that lasts over time.